What Is Methylene Blue and What Is It Made From? | Chemistry

Methylene blue is a synthetic thiazine dye with the formula C16H18ClN3S, built from aniline-family precursors through oxidation and cyclization.

The color tells you nothing about which one you’re holding — the label does. Sorting out what methylene blue is and what it is made from means reading three things: the molecule, the manufacturing process, and the grade on the package.

Methylene Blue Formula And Salt Forms

Methylene blue is an organic chloride salt in the thiazine dye family, built on a positively charged 3,7-bis(dimethylamino)phenothiazin-5-ium ion paired with a chloride ion. That charge structure is why the compound reads as intensely blue in solution and why it stains almost anything it touches, from cells to cotton to countertops.

The dye was first synthesized in 1876 as an aniline-based textile colorant and later took on work as a biological stain, an analytical reagent, and a drug. Commercial material ships as either the hydrochloride or a zinc chloride double salt, so two bottles with the same front label can differ in salt form, concentration, and purity.

Chemical Feature Methylene Blue Specification
Chemical name 3,7-bis(dimethylamino)phenothiazin-5-ium chloride
Molecular formula C16H18ClN3S
Molar mass About 319.85 g/mol
CAS Registry Number 61-73-4
First synthesized 1876, as an aniline textile dye
Commercial salt forms Hydrochloride; zinc chloride double salt
Established uses Histology staining, paper and textile dyeing, acquired methemoglobinemia

Industrial and laboratory uses run from bacteriological and histological staining through chemical analysis, paper, textile, and leather dyeing, pulp processing, and polymerization inhibition. None of those jobs requires material that is sterile or fit for human use.

What Methylene Blue Is Made From: The Synthesis Steps

The synthesis starts with aromatic amines. N,N-dimethyl-p-phenylenediamine, also written 4-aminodimethylaniline, reacts with sodium thiosulfate under oxidation to form a quinonediiminothiosulfonic acid intermediate. That intermediate then reacts with N,N-dimethylaniline, and further oxidation with cyclization closes the phenothiazine ring and produces the dye.

  1. Oxidize N,N-dimethyl-p-phenylenediamine with sodium thiosulfate to build the thiosulfonic acid intermediate.
  2. React that intermediate with N,N-dimethylaniline.
  3. Oxidize and cyclize to form the phenothiazine dye.
  4. In industrial production, sodium dichromate supplies the oxidation. The dye is isolated as the hydrochloride by adding 30% hydrochloric acid and saturated sodium chloride solution, then filtering and washing with 2% sodium chloride solution.

Precursor purity carries straight through to the finished dye. A maker working with distilled aromatic amines and a clean oxidizer ends up with a different certificate of analysis than one running cheaper feedstock, which is why two powders of identical color can behave very differently.

PubChem’s compound record for methylene blue lists the molecular formula, the CAS Registry Number 61-73-4, and the salt forms together in one entry.

Is Methylene Blue Safe To Handle?

Safety depends on the grade in your hand. The prescription drug carries two hard contraindications and a serious interaction warning, and aquarium, laboratory, industrial, and nootropic products are not equivalents of it, no matter how similar the color.

The drug works as an oxidation-reduction agent, helping reduce oxidized methemoglobin so hemoglobin can carry oxygen again.

The FDA prescribing information for PROVAYBLUE lists both contraindications and the interaction warning, and those warnings cover the prescription product only.

  • Severe hypersensitivity to methylene blue.
  • G6PD deficiency, because treatment can cause severe hemolysis and anemia.
  • Serotonin syndrome, which can be fatal, when methylene blue meets serotonergic medicines or opioids — SSRIs, SNRIs, MAOIs, and opioids among them. Concomitant use should be avoided unless a clinician directs it.

The FDA indication is deliberately narrow: acquired methemoglobinemia, not cyanosis from other causes. Mixing the two up points people toward a drug they may not need and, with G6PD deficiency or an SSRI already on board, toward genuine harm.

Handling hazards sit apart from the medical ones. Swallowed methylene blue is harmful, some classifications warn of serious eye damage, and concentrated material stains skin, clothing, and work surfaces in ways that resist ordinary cleaning. The current safety data sheet governs handling, not a forum thread.

Grades vary by supplier, so compare labeled concentration, salt form, and purity before ordering — this tested methylene blue product roundup sets those labels side by side.

Four checks that catch most methylene blue mistakes.

  • Match the grade to the job: pharmaceutical, laboratory, industrial, or aquarium.
  • Read the salt form and concentration, not just the name on the front.
  • Check G6PD status and any serotonergic medication before human use.
  • Keep it away from fabric, counters, and exposed skin.

Common Questions

Does methylene blue stain skin and clothing permanently?

Concentrated methylene blue stains skin, fabric, and hard surfaces, and the marks resist ordinary washing. Skin discoloration usually fades over days as the outer layer sheds, while fabric stains can be permanent. Gloves, an apron, and a clear work area cost far less than replacing what a spill ruins.

Is aquarium-grade methylene blue the same as the prescription drug?

No. Aquarium products are sold for water treatment, not ingestion, and nothing guarantees their sterility, concentration accuracy, or pharmaceutical purity. Treating one as a substitute for the other is the most common and most damaging mix-up with this compound.

Why is G6PD deficiency a contraindication for methylene blue?

Glucose-6-phosphate dehydrogenase protects red blood cells from oxidative stress. Without enough of the enzyme, methylene blue can push those cells to rupture, producing severe hemolysis and anemia. The prescribing information lists G6PD deficiency as a contraindication, which is why screening happens before treatment rather than after.

Sources